gbca2025_69: FDA GBCA dataset with 69 adverse events

In pvEBayes: Empirical Bayes Methods for Pharmacovigilance

FDA GBCA dataset with 69 adverse events

Description

An adverse event-drug count dataset (contingency table) obtained from the FDA FAERS database for the quarters 2021Q1 - 2024Q4

Usage

gbca2025_69

Format

An object of class matrix (inherits from array) with 70 rows and 8 columns.

Details

Data are stored in the form of a contingency table, with drugs listed across the columns and the 69 AEs presented across the rows. Each cell in the contingency table represents the total report counts associated with that (AE, drug) pair and detected in the FDA FAERS database during 2021Q1 - 2024Q4.

The dataset catalogs 7 Gadolinium-Based Contrast Agents (GBCAs) (across columns):

Gadobenate, Gadobutrol, Gadodiamide, Gadopentetate, Gadoterate, Gadoteridol, Gadoxetate.

The 69 adverse events presented across the rows are selected from 1328 AEs of gbca2025 which are related to the brain or neural system. Other AEs are collapsed to one reference row: "Other AEs".

Source

https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html

pvEBayes documentation built on Aug. 8, 2025, 6:13 p.m.